[Featured Stock] Respiratory Therapy Device Company Mecaics Up 26%
Mecics, a company specializing in respiratory therapy devices, is hitting the upper price limit.
At 10:35 AM on the 24th, Mecics is trading at 4,535 KRW, up 26.32% compared to the previous day.
This is interpreted as being influenced by the resurgence of COVID-19 in China. On the 22nd, local Chinese media reported that Chinese epidemic prevention experts predicted the peak of the second COVID-19 wave would occur by the end of next month.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Mecics is a specialized company in ventilators and respiratory therapy devices. As of the end of January, it supplied 700 units of the respiratory therapy drug HFT500 to China.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
